BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Genzyme

Genzyme is one of the world’s leading biotechnology companies. Its more than 9,000 employees work in countries throughout the world and are united by a common goal: to make a major positive impact on the lives of people with debilitating diseases. Since its founding in 1981, Genzyme has grown from a small start-up to a diversified enterprise with 2006 revenues of $3.2 billion. Over the past two decades Genzyme has introduced a number of breakthrough treatments in several areas of medicine, which have provided hope to patients who previously had no viable treatment options. Genzyme products are helping patients in nearly 90 countries. Today, Genzyme continues to be driven by its commitment to patients. The company is working to develop new medicines, improve its existing therapies, secure approvals for its products around the world, and ensure that patients have access to these treatments. Genzyme, which has its headquarters in Cambridge, Massachusetts, was selected by FORTUNE as one of the “100 Best Companies to Work for” in the United States in 2006 and 2007.


Contact Details:
500 Kendall Street
Cambridge
MA
02142
United States of America
Tel:617 252 7500
Fax:617 252 7600
Email:
WWW:

www.genzyme.com/




Loading...

Recent Publications by Genzyme:

Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry.
Fabry disease is an X-linked lysosomal disease caused by deficiency of...
4th July, 2008
Divisions of Human Genetics [R.J.H.], Division of Nephrology and Pediatr Res. 2008 Jun 25;.
DOI Direct Link
Serum and urinary biomarker signatures for rapid preclinical in vivo assessment of CDK inhibition as a therapeutic approach for PKD.
Recent advances in understanding the molecular pathogenesis of polycystic...
28th June, 2008
Cell Biology, Genzyme Corporation, Framingham, Massachusetts, USA. Cell Cycle. 2008 Apr 2;7(12).
Contemplations on preclinical validation of fluorescence in situ hybridization probe assay for paraffin-embedded tissues in hematologic disorders.
A validation of fluorescence in situ hybridization (FISH) assays for...
25th June, 2008
Genzyme Genetics, Cancer Genet Cytogenet. 2008 May;183(1):1-5.
DOI Direct Link
Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease.
Pompe disease results in the accumulation of lysosomal glycogen in...
10th June, 2008
Biologics Research and Development, Genzyme Corporation, One Mountain Mol Genet Metab. 2008 Jun 4;.
DOI Direct Link
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
Two of the three components of anthrax toxin, protective antigen (PA) and...
3rd June, 2008
Genzyme Corporation, Framingham, Int J Oncol. 2008 Apr;32(4):739-48.

View more Genzyme research publications.

BioNews Results for Genzyme:

Motesanib Effective in Progressive Differentiated Thyroid Disease
Medscape:  Jul 4 2008 5:54PM Matching: genzyme
Justice in translation: from bench to bedside in the developing world
Lancet:  Jul 4 2008 12:44AM Matching: genzyme
Sparta Systems Selected By Genzyme To Optimize Quality Assurance Processes With TrackWise
Pharmaceutical Online:  Jul 3 2008 10:09AM Matching: genzyme
Genzyme and Isis change license deal for cholesterol drug
Mass High Tech:  Jul 3 2008 3:19PM Matching: genzyme
Genzyme Corporation - SWOT Analysis - New Research Report on Companies and Markets
PR inside:  Jul 3 2008 1:38AM Matching: genzyme
Promote your company here: BioNewsCast - Press Release Distribution

View more Genzyme news.

Genzyme Patents:

US Patent No.Title
7049345 Fat-binding polymers
7122530 24-hydroxyvitamin D, analogs and uses thereof
7125547 Poly(diallylamine)-based bile acid sequestrants
7125705 Polynucleotides for use in recombinant adeno-associated virus virion production
7148211 Formulation for lipophilic agents

View more Genzyme patents.

Genzyme (GENZ) Financial information Links from Barchart

GENZ Quote from from Barchart.com
GENZ Chart from from Barchart.com
GENZ Profile from from Barchart.com
GENZ Opinion from from Barchart.com

View more Genzyme finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 103 individuals from Genzyme using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 393 times since April 2007, the link to the organisation's website has been followed 57 times

Recent Search Terms used to find this page: genzyme and rhTSH | reviews genzyme genetics | GDNF Genzyme | genzyme | www.genzyme com | Genzyme | Genzyme | genzyme.com | tasidotin | Genzyme | .

Search for more companies in Cambridge

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Genzyme
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.